Literature DB >> 25228673

Phase 3 trial with the RTS,S/AS01 malaria vaccine shows protection against clinical and severe malaria in infants and children in Africa.

Geoffrey Targett1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25228673     DOI： 10.1136/ebmed-2014-110089

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  2 in total

Review 1.  Management of severe paediatric malaria in resource-limited settings.

Authors:  Kathryn Maitland
Journal:  BMC Med       Date:  2015-03-03       Impact factor: 8.775

2.  Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.

Authors:  Kavita Singh; Martin Burkhardt; Sofia Nakuchima; Raul Herrera; Olga Muratova; Apostolos G Gittis; Emily Kelnhofer; Karine Reiter; Margery Smelkinson; Daniel Veltri; Bruce J Swihart; Richard Shimp; Vu Nguyen; Baoshan Zhang; Nicholas J MacDonald; Patrick E Duffy; David N Garboczi; David L Narum
Journal:  Commun Biol       Date:  2020-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.